NIKHIL VORA: Open Payments
NPI 1043244411 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,132 in 138 payments from 11 companies in 2025. Trend: 2023 $1,819 · 2024 $1,628 · 2025 $2,132
Food & beverage: $2,132
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 24 | $450 |
| Alkermes, Inc. | 19 | $293 |
| Lundbeck LLC | 15 | $241 |
| Axsome Therapeutics, Inc. | 14 | $212 |
| ABBVIE INC. | 20 | $211 |
| E.R. Squibb & Sons, L.L.C. | 15 | $181 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $173 |
| Otsuka America Pharmaceutical, Inc. | 7 | $156 |
| Janssen Pharmaceuticals, Inc | 4 | $90 |
| Supernus Pharmaceuticals, Inc. | 4 | $84 |
Products named: FANAPT, REXULTI, ARISTADA, Auvelity, VRAYLAR, COBENFY, CAPLYTA, Qelbree.
Industry payments across MI — which companies pay providers there.
